Sign in
4

Changes in Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-26-070248

Chairman, CEO and Interim CFO sold 4,126 shares at an average $3.18 ($13,110)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Pham Quang X · Chairman, CEO and Interim CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-16 Sale : show line 1 in the form 10b5-1 −3,613 $3.18 $11,489 129,102 D
2026-06-17 Sale : show line 2 in the form 10b5-1 −513 $3.16 $1,621 128,589 D
Open-market sales · 4,126 sh · avg $3.18 · $13,110
Loading xslF345X06/ownership.xml…